Rushworth and Megson, 2014
Fourth, long-term clinical outcomes data - cirrhosis incidence, HCC rates, liver transplantation, and liver-related mortality assessed as primary endpoints in randomized trials - are not yet available and are urgently needed to move beyond surrogate histological endpoints
10.1016/j.ejphar.2007.05.053 270 SalikH.ZhaoxiaJ.AlexiaJ.DeGraffL
Exploring the Benefits of Empagliflozin Empagliflozin, a distinguished member of the SGLT2 inhibitor class, has garnered attention not only for its effectiveness in lowering blood sugar levels but also for its broader health benefits, particularly in cardiovascular health and weight management
[4] What are the potential benefits or uses of NAD+ injections
Transdermal patches typically remain in place for periods ranging from 24 hours to seven days, depending on the specific medication and formulation